Tuberculosis, drug resistance, and the history of modern medicine.
about
Combating Tuberculosis Infection: A Forbidding ChallengeMathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel TherapiesA medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosisNatural Products for the Treatment of Chlamydiaceae InfectionsPros and cons of the tuberculosis drugome approach--an empirical analysisGlobal financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatmentPatient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, PeruTrends in TB case notification over fifteen years: the case notification of 25 Districts of Arsi Zone of Oromia Regional State, Central EthiopiaThe structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates.A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant TuberculosisFifteen-year trend in treatment outcomes among patients with pulmonary smear-positive tuberculosis and its determinants in Arsi Zone, Central Ethiopia.The factors associated with tuberculosis recurrence in the northwest and west of iran.In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatmentRole of a GenoType MTBDRplus line probe assay in early detection of multidrug-resistant tuberculosis at a Brazilian reference center.Spatiotemporal Clustering of Mycobacterium tuberculosis Complex Genotypes in Florida: Genetic Diversity Segregated by Country of Birth.Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.Reconstitution of Protein Translation of Mycobacterium Reveals Functional Conservation and Divergence with the Gram-Negative Bacterium Escherichia coliRETROSPECTIVE STUDY OF MEASURING TUBERCULOSIS THERAPY COMPLIANCE: GREECE AS A HOST COUNTRY FOR VULNERABLE POPULATIONS BEFORE AND DURING THE FINANCIAL CRISISPrevalence and Incidence of Smear-Positive Pulmonary Tuberculosis in the Hetosa District of Arsi Zone, Oromia Regional State of Central Ethiopia.Rifoligotyping assay: an alternative method for rapid detection of rifampicin resistance in Mycobacterium tuberculosis isolates from Morocco.The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology.Evolution of Microbial Quorum Sensing to Human Global Quorum Sensing: An Insight into How Gap Junctional Intercellular Communication Might Be Linked to the Global Metabolic Disease Crisis.Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis.Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisGenotypic Detection of rpoB and katG Gene Mutations Associated with Rifampicin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates: A Local Scenario (Kelantan).True facets of TB diagnosis in 2012: Hypes and realities.Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and Access.Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy.Natural products for the treatment of trachoma and Chlamydia trachomatis.Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.Newer patents in antimycobacterial therapy.The paradigm shift to end tuberculosis. Are we ready to assume the changes?Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.The changing landscape in drug resistant-tuberculosis: an analysis of recent advances.Impact of a shortage of first-line antituberculosis medication on tuberculosis control - United States, 2012-2013.Magnetic barcode assay for genetic detection of pathogens.Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009-2013.Donor-derived tuberculosis in an anesthetist after short-term exposure : An old demon transplanted from the past to the present.
P2860
Q26750683-4A7460F8-3A8C-4895-9B2F-99D0A7FC960EQ26778117-6FB4CDE7-15F6-47A5-8663-F4E0198E7239Q27004482-1EE2E0CD-00C2-45BC-B5FF-6193F79CD00CQ28066312-BA6FFDB7-3552-406A-8AC9-F40680DA837CQ28540138-6D4AB6B2-9C6D-4432-87F6-9D90D02C1CEEQ28543392-3EBCCA6A-2232-46A6-903D-A6318D172149Q28547965-F98CD932-8F54-4D99-B4DD-E7871CC82566Q31155176-11AF91EA-FAC3-4712-B2D2-8F895A65E917Q33616718-8C95CB3D-0EB0-457A-A98E-F289C971E6E2Q33939074-B9D19B85-4FC0-4C4B-AB88-4F449AF4D541Q34219326-83C9C250-837B-4139-8E4F-5E721AE7F0A5Q35341025-0711C106-989C-4F42-A68F-4D8E4D3A64D8Q35960910-A2CC35BB-234E-4533-9AE1-005A557A6902Q35971268-11F98759-A509-45EC-BDA3-D1EE0D934FADQ35993657-DD884978-D70A-4EE7-AD27-CF9BB6C79DB8Q36080613-275695F0-89B6-454B-A3B8-679967BF2782Q36114238-F3E42E50-0E17-46E8-A520-F666FD16C69AQ36264545-F15A6D6B-D433-4516-9AA2-960205220151Q36311140-89327986-BC4C-4623-8BDA-DD0290D9F25BQ36384233-A59B9817-48F6-413C-98B2-D0E7672DBBB0Q36675409-D6D6EA04-73D2-4448-AB3C-A1898749BFAAQ37021677-F3E57ED5-D16D-45D9-88A5-96049F892DF1Q37057429-C3BB7AE2-6186-45C9-B83E-1775EA6AE911Q37065759-66B10365-46B4-4293-B8BA-8DADECA047E6Q37089655-24D9C5E4-CDE4-4DB2-BD73-507163495176Q37155860-4D99DE3A-0CEC-45CB-B5CE-BA9F69103357Q37319941-22CCDE99-B224-4F2E-B584-C01BC1C7E522Q37351057-10B0708B-0D63-4B76-9087-B3C087238EF0Q37351078-0F497781-C81C-4CB4-8383-38430C4FAC1DQ37841577-39802DDB-5FBF-4191-B184-6E7124B3265FQ38059150-68C7C037-97B3-4788-8643-3B310C7A2C39Q38445649-981B388D-4704-4729-AA79-88202C9D8A87Q38510495-E502D389-91BB-4DBE-9BB1-A36B762185F2Q38676708-202035A6-8E78-4181-970A-1B9AE97AC9AFQ38842620-E778E87C-EB21-4585-996B-41E9829B3D3AQ39262652-500B14EA-7E2A-4E8F-91F8-BD576C009DA0Q39414259-C85074EA-17CA-4A3D-8CA0-00F7FB522F2AQ40071905-DE47B28C-FF50-4E9F-A3D2-972CDE50D735Q40072518-FAD635A1-97D5-4021-ACD8-0971A8851FDDQ40693600-6A02E9A2-01D8-43FB-AD3F-3A6E1C74D0DB
P2860
Tuberculosis, drug resistance, and the history of modern medicine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tuberculosis, drug resistance, and the history of modern medicine.
@ast
Tuberculosis, drug resistance, and the history of modern medicine.
@en
Tuberculosis, drug resistance, and the history of modern medicine.
@nl
type
label
Tuberculosis, drug resistance, and the history of modern medicine.
@ast
Tuberculosis, drug resistance, and the history of modern medicine.
@en
Tuberculosis, drug resistance, and the history of modern medicine.
@nl
prefLabel
Tuberculosis, drug resistance, and the history of modern medicine.
@ast
Tuberculosis, drug resistance, and the history of modern medicine.
@en
Tuberculosis, drug resistance, and the history of modern medicine.
@nl
P356
P1476
Tuberculosis, drug resistance, and the history of modern medicine.
@en
P2093
Paul E Farmer
Salmaan Keshavjee
P304
P356
10.1056/NEJMRA1205429
P407
P577
2012-09-01T00:00:00Z